Both in Pharmaceuticals
Shattuck Labs vs Climb Bio
Over the past year STTK returned +188.1% and CLYM returned +477.9%; their daily moves had a correlation of 0.16.
STTK +188.1% CLYM +477.9%Growth of $1, one year, split-adjusted
| Metric | STTK | CLYM |
|---|---|---|
| Price | $6.54 | $11.50 |
| Market cap | $656.4M | $660.5M |
| Today | +1.71% | −2.04% |
| 1 month | −7.1% | −21.1% |
| 6 months | +9.7% | +75.8% |
| Year to date | +79.2% | +187.5% |
| 1 year | +186.8% | +439.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 656.4× | — |
| Net cash | $208.3M | $183.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.6% | 74.9% |
| Short % of float | 8.6% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).